BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19325883)

  • 21. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.
    Quinlivan EB; Holley-Guthrie EA; Norris M; Gutsch D; Bachenheimer SL; Kenney SC
    Nucleic Acids Res; 1993 Jul; 21(14):1999-2007. PubMed ID: 8393562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Latency of Epstein-Barr virus is disrupted by gain-of-function mutant cellular AP-1 proteins that preferentially bind methylated DNA.
    Yu KP; Heston L; Park R; Ding Z; Wang'ondu R; Delecluse HJ; Miller G
    Proc Natl Acad Sci U S A; 2013 May; 110(20):8176-81. PubMed ID: 23625009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.
    Robinson AR; Kwek SS; Kenney SC
    PLoS Pathog; 2012 Feb; 8(2):e1002516. PubMed ID: 22346751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a prediction protocol to identify potential targets of epigenetic reprogramming by the cancer associated Epstein Barr virus.
    Flower K; Hellen E; Newport MJ; Jones S; Sinclair AJ
    PLoS One; 2010 Feb; 5(2):e9443. PubMed ID: 20195470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.
    Bhende PM; Dickerson SJ; Sun X; Feng WH; Kenney SC
    J Virol; 2007 Jul; 81(14):7363-70. PubMed ID: 17494074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome.
    Bhende PM; Seaman WT; Delecluse HJ; Kenney SC
    Nat Genet; 2004 Oct; 36(10):1099-104. PubMed ID: 15361873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.
    Nawandar DM; Ohashi M; Djavadian R; Barlow E; Makielski K; Ali A; Lee D; Lambert PF; Johannsen E; Kenney SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.
    Robinson AR; Kwek SS; Hagemeier SR; Wille CK; Kenney SC
    J Virol; 2011 Sep; 85(17):8940-53. PubMed ID: 21697476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
    Jung YJ; Choi H; Kim H; Lee SK
    J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1.
    Raver RM; Panfil AR; Hagemeier SR; Kenney SC
    J Virol; 2013 Jul; 87(14):8053-63. PubMed ID: 23678172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis of DNA methylation-dependent site selectivity of the Epstein-Barr virus lytic switch protein ZEBRA/Zta/BZLF1.
    Bernaudat F; Gustems M; Günther J; Oliva MF; Buschle A; Göbel C; Pagniez P; Lupo J; Signor L; Müller CW; Morand P; Sattler M; Hammerschmidt W; Petosa C
    Nucleic Acids Res; 2022 Jan; 50(1):490-511. PubMed ID: 34893887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression.
    Li Y; Webster-Cyriaque J; Tomlinson CC; Yohe M; Kenney S
    J Virol; 2004 Apr; 78(8):4197-206. PubMed ID: 15047835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor.
    Zalani S; Holley-Guthrie EA; Gutsch DE; Kenney SC
    J Virol; 1992 Dec; 66(12):7282-92. PubMed ID: 1331521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
    Chen YJ; Chen YL; Chang Y; Wu CC; Ko YC; Tsao SW; Chen JY; Lin SF
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation.
    Hoebe EK; Wille C; Hopmans ES; Robinson AR; Middeldorp JM; Kenney SC; Greijer AE
    J Virol; 2012 Oct; 86(20):11322-32. PubMed ID: 22896599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.
    Kolman JL; Taylor N; Gradoville L; Countryman J; Miller G
    J Virol; 1996 Mar; 70(3):1493-504. PubMed ID: 8627667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta.
    Liu P; Speck SH
    Virology; 2003 Jun; 310(2):199-206. PubMed ID: 12781707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.
    Kalla M; Schmeinck A; Bergbauer M; Pich D; Hammerschmidt W
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):850-5. PubMed ID: 20080764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Noncanonical Basic Motif of Epstein-Barr Virus ZEBRA Protein Facilitates Recognition of Methylated DNA, High-Affinity DNA Binding, and Lytic Activation.
    Weber E; Buzovetsky O; Heston L; Yu KP; Knecht KM; El-Guindy A; Miller G; Xiong Y
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.